Purple Biotech (PPBT) Stock Skyrockets ~100% on Breakthrough News – What’s Driving the Surge?
Purple Biotech (NASDAQ: PPBT) shares surged 82% to $1.06 on October 29 after announcing a manufacturing breakthrough for its tri-specific antibody IM1240. The company, recently out of Nasdaq compliance for trading under $1, plans a 2026 IND filing. Analysts remain bullish despite ongoing losses and volatility. Purple raised $6 million in September, with a shareholder meeting set for December 15.
